These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 33292291)

  • 21. Uncertainty analysis based on probability bounds (p-box) approach in probabilistic safety assessment.
    Karanki DR; Kushwaha HS; Verma AK; Ajit S
    Risk Anal; 2009 May; 29(5):662-75. PubMed ID: 19302279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of Prostate Health Index for prostate cancer detection.
    Nichol MB; Wu J; Huang J; Denham D; Frencher SK; Jacobsen SJ
    BJU Int; 2012 Aug; 110(3):353-62. PubMed ID: 22077934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme.
    Claxton K; Ginnelly L; Sculpher M; Philips Z; Palmer S
    Health Technol Assess; 2004 Jul; 8(31):1-103, iii. PubMed ID: 15248937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probabilistic Sensitivity Analysis in Cost-Effectiveness Models: Determining Model Convergence in Cohort Models.
    Hatswell AJ; Bullement A; Briggs A; Paulden M; Stevenson MD
    Pharmacoeconomics; 2018 Dec; 36(12):1421-1426. PubMed ID: 30051268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of representing adherence to blood glucose monitoring through visualizations: A pilot survey study among healthcare workers.
    Chen Y; Kao SL; Tan M; Ning Y; Salloway M; Wee HL; Venkataraman K; Khoo EYH; Chow YL; Tai ES; Tan CS
    Int J Med Inform; 2018 Dec; 120():172-178. PubMed ID: 30409342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probabilistic sensitivity analysis: be a Bayesian.
    Boshuizen HC; van Baal PH
    Value Health; 2009; 12(8):1210-4. PubMed ID: 19695002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of alemtuzumab for T-cell prolymphocytic leukemia.
    Lu L; Peters J; Roome C; Stein K
    Int J Technol Assess Health Care; 2012 Jul; 28(3):241-8. PubMed ID: 22980700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Time Traveling Is Just Too Dangerous" but Some Methods Are Worth Revisiting: The Advantages of Expected Loss Curves Over Cost-Effectiveness Acceptability Curves and Frontier.
    Alarid-Escudero F; Enns EA; Kuntz KM; Michaud TL; Jalal H
    Value Health; 2019 May; 22(5):611-618. PubMed ID: 31104743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cost-effectiveness analysis of MMX mesalazine compared with mesalazine in the treatment of mild-to-moderate ulcerative colitis from a UK perspective.
    Brereton N; Bodger K; Kamm MA; Hodgkins P; Yan S; Akehurst R
    J Med Econ; 2010 Mar; 13(1):148-61. PubMed ID: 20141380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cost-effectiveness of testing for hepatitis C in former injecting drug users.
    Castelnuovo E; Thompson-Coon J; Pitt M; Cramp M; Siebert U; Price A; Stein K
    Health Technol Assess; 2006 Sep; 10(32):iii-iv, ix-xii, 1-93. PubMed ID: 16948891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Information Guided Exploration of Scalar Values and Isocontours in Ensemble Datasets.
    Hazarika S; Biswas A; Dutta S; Shen HW
    Entropy (Basel); 2018 Jul; 20(7):. PubMed ID: 33265629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model.
    Crathorne L; Huxley N; Haasova M; Snowsill T; Jones-Hughes T; Hoyle M; Briscoe S; Coelho H; Long L; Medina-Lara A; Mujica-Mota R; Napier M; Hyde C
    Health Technol Assess; 2016 Feb; 20(13):1-588, v-vi. PubMed ID: 26907163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of probabilistic decision models in technology assessment : the case of total hip replacement.
    Briggs A; Sculpher M; Dawson J; Fitzpatrick R; Murray D; Malchau H
    Appl Health Econ Health Policy; 2004; 3(2):79-89. PubMed ID: 15702945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate specific antigen density of the transition zone for predicting pathological stage of localized prostate cancer in patients with serum prostate specific antigen less than 10 ng./ml.
    Zlotta AR; Djavan B; Petein M; Susani M; Marberger M; Schulman CC
    J Urol; 1998 Dec; 160(6 Pt 1):2089-95. PubMed ID: 9817330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of health coaching and financial incentives to promote physical activity after total knee replacement.
    Smith KC; Paltiel AD; Yang HY; Collins JE; Katz JN; Losina E
    Osteoarthritis Cartilage; 2018 Nov; 26(11):1495-1505. PubMed ID: 30092263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probabilistic sensitivity analysis in cost-effectiveness. An application from a study of vaccination against pneumococcal bacteremia in the elderly.
    Whang W; Sisk JE; Heitjan DF; Moskowitz AJ
    Int J Technol Assess Health Care; 1999; 15(3):563-72. PubMed ID: 10874382
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.